Abstract. WNT5A is a cancer-associated gene involved in invasion and metastasis of melanoma, breast cancer, pancreatic cancer, and gastric cancer. WNT5A transduces signals through Frizzled, ROR1, ROR2 or RYK receptors to ß-catenin-TCF/ LEF, DVL-RhoA-ROCK, DVL-RhoB-Rab4, DVL-Rac-JNK, DVL-aPKC, Calcineurin-NFAT, MAP3K7-NLK, MAP3K7-NF-κB, and DAG-PKC signaling cascades in a contextdependent manner. SNAI1 (Snail), CD44, G3BP2, and YAP1 are WNT5A target genes. We and other groups previously reported that IL6-or LIF-induced signaling through JAK-STAT3 signaling cascade is involved in WNT5A upregulation (STAT3-WNT5A signaling loop). Here, refined integrative genomic analyses of WNT5A were carried out to elucidate other mechanisms of WNT5A transcription. The WNT5A gene was found to encode two isoforms by using alternative first exons 1A and 1B. Quadruple Smad-binding elements (SBEs), single Sp1-binding site (GC-box), PPARÁ-binding site, C/EBPbinding site and bHLH-binding site within the promoter A region, 5'-adjacent to exon 1A, were conserved in human WNT5A, chimpanzee WNT5A, mouse Wnt5a, and rat Wnt5a. NF-κB-binding site, CUX1-binding site, double SBEs and double GC-boxes within the promoter B region, 5'-adjacent to exon 1B, were conserved in mammalian WNT5A orthologs. Quadruple FOX-binding sites and double SBEs within ultraconserved intron 1 were also conserved in mammalian WNT5A orthologs. Conserved NF-κB-binding site within the WNT5A promoter B region elucidated the mechanisms that TNF· and toll-like receptor (TLR) signals upregulate WNT5A via MAP3K7. Quadruple FOX-binding sites rather than GLIbinding site revealed that Hedgehog signals induce WNT5A upregulation indirectly via FOX family members, such as FOXA2, FOXC2, FOXE1, FOXF1 and FOXL1. TGFß signals were found to upregulate WNT5A expression directly through the Smad complex, and also indirectly through Smadinduced CUX1 and MAP3K7-mediated NF-κB. Together these facts indicate that WNT5A is transcribed based on multiple mechanisms, such as NF-κB, Hedgehog, TGFß, and Notch signaling cascades.
Introduction
WNT signaling cascades are involved in a variety of cellular processes during embryogenesis and carcinogenesis (1) (2) (3) (4) . Because biological functions of human genes and those of model-animal orthologs are not always conserved due to protein evolution and promoter evolution, we have carried out the human WNTome project for the comprehensive characterization of human genes encoding WNT signaling molecules during the genomic era before 2003 (5) . Nineteen WNT family genes in the human genome are conserved in the mammalian genomes (6) .
The WNT5A gene at human chromosome 3p14.3 (7, 8) is the paralog of the WNT5B gene at human chromosome 12p13.33 (9) . Human WNT5A shows 98.7% total amino-acid identity with rodent Wnt5a (10, 11) , indicating that mammalian WNT5A orthologs are ultra-conserved. Frizzled family members (12) (13) (14) , ROR1 (15) , ROR2 (16) , and RYK (17) are WNT5A receptors. WNT5A signals are transduced to the ß-catenin-TCF/LEF (12) , DVL-RhoA-ROCK (18) , DVL-RhoB-Rab4 (19) , DVL-Rac-JNK (16) , DVL-aPKC (20) , Ca 2+ -Calcineurin-NFAT (21) , Ca 2+ -MAP3K7-NLK (18, 22) , Ca 2+ -MAP3K7-NF-κB (15) , and DAG-PKC (23) signaling cascades in a context-dependent manner (13, 24, 25) .
WNT5A is expressed in a variety of human tumors (Table I) , including breast cancer (8, (26) (27) (28) , lung cancer (26, 29) , melanoma (26, 30) , osteosarcoma (26) , prostate cancer (26, 31, 32) , endometrial uterine cancer (33, 34) , colorectal cancer (34) (35) (36) , pancreatic cancer (37, 38) , gastric cancer (34), esophageal cancer (39) , embryonal tumor (39), Ewing sarcoma (40) , neuroblastoma (41) , skin basal cell carcinoma (BCC) (42) , skin squamous cell carcinoma (SCC) (43) , and leukemia (44, 45) . SNAI1 (Snail), CD44, G3BP2, and YAP1 are WNT5A target genes (23) . WNT5A is involved in invasion, peritoneal dissemination, and distant metastasis of tumor cells via RhoB and Snail (18, 19, 23, 46) .
We and other groups previously reported that IL6-or LIF-induced signaling through JAK-STAT3 signaling cascade is involved in WNT5A upregulation (STAT3-WNT5A signaling loop) (46) (47) (48) . Here, refined integrative genomic analyses of WNT5A were carried out to elucidate the mechanisms of WNT5A transcription other than the STAT3-WNT5A signaling loop.
Materials and methods
Comparative genomic analyses. Human genome sequences corresponding to human WNT5A RefSeq (NM_003392. 3) were searched for by using BLAST programs, as previously described (49, 50) . WNT5A expressed sequence tags (ESTs) were also searched for to identify WNT5A splicing variants (51, 52) . Conserved transcription factor-binding sites within WNT5A promoters were then searched for based on manual inspection, as previously described (53, 54) .
Regulatory network analyses. Literature on WNT5A, Hedgehog, TGFß, Notch and inflammatory signaling molecules in PubMed and Medline databases was critically evaluated to Table I . WNT5A expression in human cancer. 
extract knowledge on the regulation of GLI, FOX, SMAD, and NF-κB transcription factors. The mechanisms of WNT5A transcription were then investigated based on our data of conserved transcription factor-binding sites within WNT5A promoters and in-house knowledgebase of transcription factors regulated by the stem-cell signaling network.
Results

WNT5A splicing variants transcribed by using alternative promoters.
Human WNT5A gene is located within human genome sequence AC121764.2, as previously described (11) . BLAST programs using the WNT5A genome sequence revealed that human ESTs CB988958.1, CF994133.1, DA459745.1, DA874427.1 and DB276659.1 were transcribed from exon 1, and that human ESTs DA030580.1, DA650006.1 and DB224740.1 were transcribed from alternative first exon located between exon 1 and exon 2. To distinguish two alternative first exons of human WNT5A gene, exon 1 was renamed exon 1a, and alternative first exon was designated exon 1b ( Fig. 1 ). WNT5A isoform A (NM_003392.3 RefSeq) consists of exons 1a, 2, 3, 4 and 5, whereas WNT5A isoform B (AK290869.1 cDNA) consists of exons 1b, 2, 3, 4 and 5.
Comparative genomics on mammalian WNT5A orthologs. Rat Wnt5a gene is located within AC095764.5 incomplete genome sequence with gaps, as previously described (11) . To our surprise, AC095764.5 draft sequence had not been replaced by complete genome sequence since September 22, 2002 . BLAST programs next revealed that chimpanzee WNT5A gene and mouse Wnt5a gene were located within NW_001232823.1 draft sequence and CT025649.7 complete sequence, respectively (data not shown).
Comparative genomic analyses of mammalian WNT5A orthologs revealed that the WNT5A promoter A region located at the 5'-adjacent position of exon 1a, the WNT5A promoter B region located at the 5'-adjacent position of exon 1b and WNT5A intron 1 located between exon 1b and exon 2 were well conserved in mammalian WNT5A orthologs (Fig. 1) .
Conserved transcription factor-binding sites within WNT5A regulatory regions. We previously identified the evolutionary conservation between the promoter A region of human WNT5A gene and that of rat Wnt5a gene (11), whereas Danielson et al identified putative transcription factor-binding sites within the promoter B of human WNT5A gene without any information on evolutionary conservation (7). Because database of mammalian genome sequences and knowledgebase of transcription factor-binding sites have been quantitatively and qualitatively improved during the past three years, refined integrative genomic analyses of WNT5A regulatory regions were next carried out.
WNT5A promoter A without TATA-box is predicted to show 'broad peak' pattern of transcription start sites (TSSs). We utilized the most 5'-TSS of WNT5A in our previous study (11) ; however, TSS of NM_003392.3 RefSeq was 338-bp 3'-position compared with the most 5'-TSS. Based on manual inspection of the promoter A region, we found that PPARÁ-binding site, Sp1-binding site (GC-box), C/EBP-binding site, bHLH-binding site and quadruple Smad-binding elements (SBEs) within the promoter A region were completely conserved in human WNT5A, chimpanzee WNT5A, mouse Wnt5a, and rat Wnt5a genes (Fig. 1) .
WNT5A promoter B was less conserved compared with WNT5A promoter A (data not shown). CUX1 (CUTL1)-binding site, double SBEs, and double GC-boxes within the promoter B region were completely conserved in human WNT5A, chimpanzee WNT5A, mouse Wnt5a, and rat Wnt5a genes (Fig. 1) . NF-κB-binding site within the promoter B region was completely conserved in human WNT5A, chimpanzee WNT5A, and mouse Wnt5a genes, and was almost conserved in rat Wnt5a gene except one-base substitution (Fig. 1) . Because rat genome sequence AC095764.5 was incomplete as mentioned above, we next searched for the existence of the NF-κB-binding site within other mammalian WNT5A orthologs, and found that the NF-κB-binding site was also conserved in the cow WNT5A ortholog (Fig. 1) .
WNT5A intron 1 was ultra-conserved among mammals. For example, inton 1 of human WNT5A gene showed 87.9% total nucleotide identity with that of mouse Wnt5a gene (data not shown). Manual inspection of transcription factor-binding sites then revealed that quadruple FOX-binding sites and double SBEs were completely conserved in human WNT5A, chimpanzee WNT5A, and mouse Wnt5a genes (Fig. 1) . Most of these transcription factor-binding sites, except the third FOX-binding site, were also completely conserved in the rat Wnt5a gene (Fig. 1) .
Conserved NF-κB-binding site, FOX-binding sites, SBEs and CUX1-binding site within the regulatory regions of WNT5A orthologs were novel findings in this study (Fig. 1) .
NF-κB signaling cascades and WNT5A.
Chronic inflammation is involved in tumor progression via activation of STAT3 and NF-κB transcription factors (46, 48, (55) (56) (57) (58) (59) . We have previously reported the mechanisms of IL6-or LIF-induced WNT5A upregulation via STAT3 (46), and McCall et al reported the involvement of the IL6-STAT3 signaling loop in WNT5A upregulation in papillary thyroid carcinoma (48) . Mechanisms of NF-κB-mediated WNT5A upregulation will be described in this section.
TNF receptors (TNFRs), Toll-like receptors (TLRs), IL1 receptors (IL1Rs), and TGFß receptors (TGFßRs) are involved in MAP3K7-mediated IKK activation (58) . IKK then phosphorylates IκB to induce ubiquitin-mediated degradation, which results in stabilization and activation of NF-κB (56 (60) . Because NF-κB-binding site within WNT5A promoter B was conserved in mammals ( Fig. 1) , it was concluded that WNT5A is upregulated by TNF·, TLR, IL1, and TGFß signaling activation via NF-κB (Fig. 2) .
Hedgehog signaling cascades and WNT5A. Hedgehog signals are transduced through Patched family receptors and Smoothened signal transducer to GLI transcriptional activators (61) (62) (63) . Hedgehog signals are activated in gastric cancer (64, 65) , basal cell carcinoma (66) , and other tumors. WNT5A is expressed in gastric cancer (34) , basal cell carcinoma (42) , and other tumors, as mentioned above. Due to the co-existence of Hedgehog signaling activation and WNT5A expression in human tumors, causal relationship between Hedgehog signaling activation and WNT5A expression was investigated.
Consensus GLI-binding site was not located within WNT5A promoters and WNT5A gene (data not shown). FOXA2, FOXC2, FOXE1, FOXF1 and FOXL1 are direct target genes of Hedgehog-GLI signaling cascade (63) , and quadruple FOXbinding sites within human WNT5A intron 1 were conserved in chimpanzee WNT5A, cow WNT5A, and mouse Wnt2b (Fig. 1 ). Together these facts indicate that Hedgehog signals induce WNT5A upregulation indirectly through FOX family members (Fig. 2) .
TGFß signaling cascades and WNT5A. TGFß signals are transduced through receptor-type serine/threonine kinases to Smad2/3-Smad4 transcriptional complex and MAP3K7-NF-κB signaling cascade (67, 68) . Smad2/3-Smad4 complex, binding to the SBE of target genes, is associated with other transcription factors, such as Sp1 and ETS for transcriptional regulation of TGFß-target genes. TGFß-induced upregulation of CDNK1A (P16) and CDKN2B (P15) is involved in growth inhibition of tumor cells, whereas TGFß-induced upregulation of EMT regulators is involved in invasion, peritoneal dissemination, and distant metastasis of tumor cells. Roarty and Serra reported that TGFß-induced Wnt5a upregulation is required for proper mammary gland development (69). Ripka et al reported that TGFß induces WNT5A upregulation via CUX1 (70); however, CUT1-binding site within the WNT5A regulatory regions remained unclear. Causal link between TGFß signaling activation and WNT5A expression was next investigated.
Quadruple SBEs within the promoter A region, double SBEs within the promoter B region, and double SBEs within intron 1 were conserved in mammalian WNT5A orthologs; single GC-box within the promoter A region and double GCboxes within the promoter B region were conserved in mammalian WNT5A orthologs; single CUX1-binding site within the promoter B region was conserved in mammalian WNT5A orthologs (Fig. 1) . In addition, NF-κB-binding site within the promoter B region was conserved in mammalian WNT5A orthologs, as discussed above. Together these facts indicate that TGFß signals upregulate WNT5A expression directly through the Smad complex, and also indirectly through Smad-induced CUX1 and MAP3K7-mediated NF-κB (Fig. 2) . (74); however, the mechanism of Notch-mediated WNT5A upregulation remained to be elucidated. Manual inspection in this study revealed that consensus CSL-binding site within WNT5A regulatory regions was not conserved in mammals (data not shown). On the other hand, NF-κB-binding site within the promoter B region was conserved in mammalian WNT5A orthologs, as discussed above. Together these facts indicate that Notch signals upregulate WNT5A expression via the NICD-NF-κB complex (Fig. 2) .
Discussion
Refined integrative genomic analyses of WNT5A orthologs were carried out in this study. The WNT5A gene was found to encode two transcripts by using alternative first exons 1A and 1B (Fig. 1) . Comparative genomic analyses revealed that the promoter A region, promoter B region, and intron 1 were well conserved in mammalian WNT5A orthologs (Fig. 1) .
Transcription factor-binding sites within the conserved WNT5A regulatory regions were searched for in this study. Quadruple SBEs, single GC-box, PPARÁ-binding site, C/EBPbinding site, and bHLH-binding site within the promoter A region were conserved in human WNT5A, chimpanzee WNT5A, mouse Wnt5a, and rat Wnt5a; NF-κB-binding site, CUX1-binding site, double SBEs and double GC-boxes within the promoter B region were conserved in mammalian WNT5A orthologs; quadruple FOX-binding sites and double SBEs within ultra-conserved intron 1 were also conserved in the mammalian WNT5A orthologs (Fig. 1) .
Conserved NF-κB-binding site within WNT5A promoter B region elucidated the mechanisms that TNF· and TLR signals upregulate WNT5A via MAP3K7. Quadruple FOXbinding sites within the WNT5A enhancer region and absence of GLI-binding site around and within the WNT5A gene revealed that Hedgehog signals induce WNT5A upregulation indirectly via FOX family members rather than directly via GLI activators. TGFß signals were found to upregulate WNT5A expression directly through the Smad complex, and also indirectly through Smad-induced CUX1 and MAP3K7-mediated NF-κB. Together these facts indicate that WNT5A is transcribed due to multiple mechanisms, such as NF-κB, Hedgehog, TGFß, and Notch signaling activation.
WNT signaling cascades cross-talk with FGF, Notch, Hedgehog, and TGFß/BMP signaling cascades constituting the stem cell signaling network (75) (76) (77) . Chronic inflammation is involved in carcinogenesis through tumor-stromal interaction activating STAT3 and NF-κB signaling cascades, and also through epigenetic alterations of the stem-cell signaling molecules (55) (56) (57) . Results obtained in this study clearly indicate that WNT5A is the key molecule at the crossroads of inflammation and carcinogenesis. Because next-generation sequence technology and peta-scale supercomputer are emerging to open up the frontier of personalized medicine (78) , large scale analyses of single nucleotide polymorphisms (SNPs) and copy number variations (CNVs) of the WNT5A gene in melanoma, breast cancer, lung cancer, pancreatic cancer and gastric cancer should be carried out with the stratification based on the co-existence of environmental insults, such as ultraviolet exposure, tobacco smoking, and chronic infection.
